Elekta AB Class B

EKTA B: XSTO (SWE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$TLOCK|$MLOCK|b!Nc&sq

Elekta's Turnaround Signs Are Present but Challenges Remain

Business Strategy and Outlook

Demand for radiotherapy should stay healthy over the next decade. Elekta stands to benefit from the industrywide tailwind, but its recent performance has been challenging. Siemens Healthineers has been able to gain market share globally due to its size and relationship with large hospital networks. Elekta's position is still formidable, but the future success hinges on the uptake of its latest product platform, as well as growing adoption of Unity.

Sponsor Center